|
Sign In to gain access to subscriptions and/or personal tools.
|
SMOKELESS TOBACCO AND ORAL CANCER: A REVIEW OF THE RISKS AND DETERMINANTS
Brad Rodu* and
Christer Jansson
1 Department of Pathology, School of Medicine, LHRB 156, University of Alabama at Birmingham, Birmingham, AL 35294-0007, USA;
2 Research and Development Department, Swedish National Food Administration, Uppsala, Sweden

View larger version (20K):
[in this window]
[in a new window]
|
Figure 1. Summary RRs for oral cancer and related sites according to SLT product type. Adapted from Rodu and Cole (2002). Oral Cav = Oral Cavity; Ph = Pharynx; La = Larynx.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Figure 2. Historical levels of total tobacco-specific nitrosamines (TSNAs) (ppm) in American and Swedish moist snuff products, 1981–2002. Sources: Hoffmann and Adams, 1981; Österdahl and Slorach, 1984; Hoffmann et al., 1984, 1986, 1988, 1991, 1995; Brunnemann et al., 1985, 1987, 2002; Chamberlain et al., 1988; Djordjevic et al., 1989, 1993.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Figure 3. Historical levels of N-nitrosonornicotine (NNN) + 4-methyl-N-nitrosamino-1-(3-pyridyl)-1-butanone (NNK) (ppm) in American and Swedish moist snuff products, 1981–2002. Sources as for Fig. 2 .
|
|
Critical Reviews in Oral Biology & Medicine, Vol. 15, No. 5,
252-263 (2004)
DOI: 10.1177/154411130401500502

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|